Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource, 1 online resource.
Sprache
Englisch

Erschienen in
Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology ; volume:18 ; number:1 ; day:24 ; month:6 ; year:2023 ; pages:1-21 ; date:12.2023
Molecular neurodegeneration ; 18, Heft 1 (24.6.2023), 1-21, 12.2023

Urheber
Lee, Jihoon
Sung, Ki Woon
Bae, Eun-Jin
Yoon, Dabin
Kim, Dasarang
Lee, Jin Saem
Park, Da-ha
Park, Daniel Youngjae
Mun, Su Ran
Kwon, Soon Chul
Kim, Hye Yeon
Min, Joo-Ok
Lee, Seung-Jae
Suh, Young Ho
Kwon, Yong Tae
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13024-023-00630-7
URN
urn:nbn:de:101:1-2023092610563343207976
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:50 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Lee, Jihoon
  • Sung, Ki Woon
  • Bae, Eun-Jin
  • Yoon, Dabin
  • Kim, Dasarang
  • Lee, Jin Saem
  • Park, Da-ha
  • Park, Daniel Youngjae
  • Mun, Su Ran
  • Kwon, Soon Chul
  • Kim, Hye Yeon
  • Min, Joo-Ok
  • Lee, Seung-Jae
  • Suh, Young Ho
  • Kwon, Yong Tae
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Correction: Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology

Correction: Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology

Dermal α-synuclein oligomers and aggregates in Parkinson’s disease

Dermal α-synuclein oligomers and aggregates in Parkinson’s disease

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease

Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients

Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam

Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Transmission of alpha-synuclein in Parkinson’s disease

Transmission of alpha-synuclein in Parkinson’s disease

Oligomerization, Degradation and Aggregation Reactions and Products of Synuclein Polypeptides Related to Parkinson’s Disease

Hochschulschrift

Oligomerization, Degradation and Aggregation Reactions and Products of Synuclein Polypeptides Related to Parkinson’s Disease

Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Models of α-synuclein aggregation in Parkinson’s disease

Models of α-synuclein aggregation in Parkinson’s disease

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model

Novel targeted therapies for Parkinson’s disease

Novel targeted therapies for Parkinson’s disease

Verbundene Objekte